AlphAIAlphAI — Financial news for AI agents
rttnews.comNOV 21 min read$TEM

Tempus AI Stock Rises 4% As Q3 Loss Narrows And Revenue Grows

Tempus AI (TEM) shares rose 4.32% to $75.34 after Q3 results showed a narrowed net loss of $14.85M and revenue growth to $411.54M. Adjusted earnings were $13.36M. The company forecasts 2026 revenue of $1.6B-$1.605B.

Original reporting
rttnews.com
Published Nov 2, 2026, 3:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 7:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$TEM
Bullish
high confidence
Mentioned
$TEM
Relevance
7/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$TEMBullishHigh
01

Why it matters

The earnings beat lifts sentiment, but the company still reports a loss, so upside may be limited.

02

Market read

Earnings-driven price move with potential short‑term trading opportunity.

03

What to watch

Future guidance range is tight; any miss could reverse the price gain quickly.

Relevance 7/10Novelty 8/10Timing: today after market close

Background

Tempus AI is a Nasdaq‑listed AI‑driven healthcare data company. The Q3 release marks a significant improvement over the prior year.

Company-level read

Ticker impact

$TEMBullishHigh confidence
Context

Tempus AI reported Q3 loss narrowing to $14.85M and revenue growth to $411.5M, driving a 4.3% price rise.

Expected impact

upward pressure as investors price in improved earnings and guidance.

Evidence & confidence

The company narrowed its loss dramatically year‑over‑year and beat revenue expectations, prompting a 4% intraday gain.

Market effects

Sector

AI‑related services sector may see modest uplift from the earnings beat.

Regional

US Nasdaq‑listed AI stocks could experience short‑term buying interest.

Global

Limited to investors tracking AI and data‑analytics firms.

Counterpoint

What could challenge this read

The loss, though narrowed, remains sizable; the rally may be short‑lived if guidance falls short.

Key entities

  • company
    Tempus AI, Inc.

    AI‑driven healthcare data platform reporting Q3 results.

Read at source← All news

StoryTempus AI posts record Q3 revenue, first adjusted profit and raises full‑year outlook

Also covered by

6 outlets

Related articles

NOV 3
$TEMLow

Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70

Jefferies upgraded Tempus AI (TEM) from Underperform to Hold, raising its price target to $70. The stock, currently at $78.48, has gained 43% in six months. The firm cited strong revenue growth, strategic collaborations, and FDA approval plans. Tempus reported Q3 2026 earnings of $0.07 per share, beating estimates, with revenue up 23% to $411.5 million. Needham raised its price target to $89, citing data business growth.

investing.com2 min
NOV 3
$TEMMed

Tempus AI Inc (TEM) Q3 2026 Earnings Call Highlights: Revenue Jumps 23%

Tempus AI Inc (TEM) reported Q3 2026 revenue of $411M, up 23%. CEO Lefkofsky expects sustainable 25%+ growth, with oncology and data segments driving performance. The company anticipates mid-2027 breakeven for Personalis' MRD test and predicts strong market share in MRD. Tempus also highlighted long-term data business commitments and AI-driven customer stickiness.

finance.yahoo.com2 min
NOV 2
$TEMMedAI 8/10

Tempus AI (TEM): Oncology Volume Surge and Data Licensing Bookings Signal a Profitable Inflection

Tempus AI (TEM) reported Q3 2026 revenue of $411.5M, up 23% YoY, with adjusted EBITDA of $25.6M. Oncology revenue grew 28% to $172.6M, while Data and Applications revenue increased 33% to $108.1M. The company raised full-year revenue guidance to $1.60B-$1.605B and expects near-term catalysts from reimbursement improvements and the pending $1.7B Personalis acquisition.

news.alphastreet.com7 min